Order Article Reprints

Al-Bazz DY, Nelson AJ, Burgess J, Petropoulos IN, Nizza J, Marshall A, Brown E, Cuthbertson DJ, Marshall AG, Malik RA, et al. Is Nerve Electrophysiology a Robust Primary Endpoint in Clinical Trials of Treatments for Diabetic Peripheral Neuropathy? Diagnostics. 2022; 12(3):731. https://doi.org/10.3390/diagnostics12030731

Al-Bazz, Dalal Y., Andrew J. Nelson, Jamie Burgess, Ioannis N. Petropoulos, Jael Nizza, Anne Marshall, Emily Brown, Daniel J. Cuthbertson, Andrew G. Marshall, Rayaz A. Malik, and et al. 2022. "Is Nerve Electrophysiology a Robust Primary Endpoint in Clinical Trials of Treatments for Diabetic Peripheral Neuropathy?" Diagnostics 12, no. 3: 731. https://doi.org/10.3390/diagnostics12030731

Al-Bazz, D. Y., Nelson, A. J., Burgess, J., Petropoulos, I. N., Nizza, J., Marshall, A., Brown, E., Cuthbertson, D. J., Marshall, A. G., Malik, R. A., & Alam, U. (2022). Is Nerve Electrophysiology a Robust Primary Endpoint in Clinical Trials of Treatments for Diabetic Peripheral Neuropathy? Diagnostics, 12(3), 731. https://doi.org/10.3390/diagnostics12030731